FIELD: chemistry.
SUBSTANCE: present invention refers to the componds of formula I 
and to physiologically endurable acid addtion salts of the mentioned compounds. The formula I compounds and their pharmaceutically acceptable salts can be used for preparation of pharmaceutical compositions in order to cure medical abnormalities responsive to dopamine D3 receptor ligand treatment.
EFFECT: preparation of pharmaceutical compositions in order to cure medical abnormalities responsive to dopamine D3 receptor ligand treatment.
47 cl, 2 tbl, 81 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ISOQUINOLINONE DERIVATIVES USEFUL IN TREATING CANCER | 2015 |
|
RU2690853C2 |
| SUBSTITUTED PYRAZOLONE COMPOUNDS AND METHODS OF USE | 2013 |
|
RU2650895C2 |
| NOVEL PIRIDAZONES AND TRIAZINONES FOR TREATMENT AND PREVENTING OF HEPATITIS B VIRUS INFECTION | 2015 |
|
RU2664329C1 |
| PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS FOR APPLICATION | 2012 |
|
RU2638552C2 |
| PD-L1 ANTAGONIST COMPOUND | 2020 |
|
RU2823231C1 |
| 3'-SUBSTITUTABLE DERIVATIVES OF ABSCISIC ACID | 2015 |
|
RU2688347C2 |
| ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 |
|
RU2717101C1 |
| HYBRID DERIVATIVES OF (1H-1,2,4) TRIAZOLE AND SULPHUR-CONTAINING HETEROCYCLES: DERIVATIVES OF THIAZOLIDINE-2,4-DIONE, THIOMORPHOLINE-3-ONE, AND 1,4-THIAZEPAN-3-ONE, EXHIBITING ANTIMICROBIAL ACTIVITY | 2020 |
|
RU2771027C1 |
| BENZIMIDAZOLE-2-PIPERAZINE HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD AND USE THEREOF | 2014 |
|
RU2649002C2 |
| COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
